Burden of metabolic dysfunction–associated steatotic liver disease in the Asia-Pacific region from 1990 to 2023
Burden of metabolic dysfunction–associated steatotic liver disease in the Asia-Pacific region from 1990 to 2023
Background: metabolic dysfunction-associated steatotic liver disease (MASLD) is an increasing health problem in the Asia-Pacific region, contributing significantly to morbidity and healthcare burden. This study provides a comprehensive analysis of the burden of MASLD across countries and territories in the Asia-Pacific region from 1990 to 2023.
Methods: we used the Global Burden of Disease 2023 data set to assess the burden of MASLD in the Asia-Pacific region, calculating age-standardised prevalence, incidence, death and disability-adjusted life year (DALY) rates. Temporal trends, age-specific and sex-specific patterns, and the relationship between MASLD burden and Socio-demographic Index (SDI) were also analysed, along with regional variations driven by ageing, population growth and epidemiological changes.
Results: in 2023, MASLD prevalence varied across the Asia-Pacific region, with the highest rates in Oceania (15 360.55 per 100 000), Central Asia (15 201.10 per 100 000), South-East Asia (15 116.91 per 100 000) and East Asia (15 042.06 per 100 000), and lower rates in Australasia (9336.02 per 100 000) and high-income regions (8654.71 per 100 000). Over the past three decades, MASLD prevalence has increased across all regions, with the largest growth in Australasia (29%) and East Asia (27%). In addition, marked regional disparities were observed in age-standardised death and DALY rates, with Central Asia exhibiting the highest health loss across the region. Age-stratified analyses revealed that the highest incidence occurred in individuals aged 20–24 years in 2023. MASLD burden followed an inverse U-shaped pattern with SDI, increasing in regions with lower SDI and decreasing in those above 0.62. Population growth and lifestyle changes were the primary drivers of MASLD in East Asia, while ageing significantly contributed to the rising burden in South Asia.
Conclusions: MASLD is increasingly prevalent across the Asia-Pacific region, driven by ageing, population growth and epidemiological changes, with significant regional variations in the disease burden.
Fatty Liver, Global Burden of Disease, Metabolic diseases, Non-alcoholic Fatty Liver Disease, Socioeconomic Factors
e100369
Zhou, Xiao-Dong
35c47d73-66c8-4e0c-95ca-326d9bc4722e
Chen, Qin-Fen
8f2d04e9-7e4d-408d-8f20-110c0f87be35
Targher, Giovanni
d857832f-c80d-4b2f-ba4e-fd8b4c90545f
Byrne, Chrisopher D.
1370b997-cead-4229-83a7-53301ed2a43c
Valenti, Luca
684b0060-3a31-4eb3-a11f-d8742eb5e585
Muthiah, Mark D.
68d6a7bc-44d8-42e2-96ce-0ad74b36153e
Kim, Seung Up
ce2558a1-dfee-4feb-9370-0fddd4739e89
Huang, Daniel Q.
2b92f945-a7fb-4b34-8bf0-402d4991e929
Yoneda, Masato
9ff5455a-fde1-497f-b088-f3d422a70e8b
Li, Wenhao
55630e3a-52a1-4bbf-bf34-ec149907131f
Yilmaz, Yusuf
33d27e59-fddc-4950-b464-21fb6bfe5750
Tilg, Herbert
2a1f1540-0e25-48b6-872f-8033a76566fa
Wong, Vincent Wai-Sun
2edb798e-8930-4191-94f2-d22713f9678b
Zheng, Ming-Hua
986e37ab-28f9-4b26-afc5-9b2383df272a
31 March 2026
Zhou, Xiao-Dong
35c47d73-66c8-4e0c-95ca-326d9bc4722e
Chen, Qin-Fen
8f2d04e9-7e4d-408d-8f20-110c0f87be35
Targher, Giovanni
d857832f-c80d-4b2f-ba4e-fd8b4c90545f
Byrne, Chrisopher D.
1370b997-cead-4229-83a7-53301ed2a43c
Valenti, Luca
684b0060-3a31-4eb3-a11f-d8742eb5e585
Muthiah, Mark D.
68d6a7bc-44d8-42e2-96ce-0ad74b36153e
Kim, Seung Up
ce2558a1-dfee-4feb-9370-0fddd4739e89
Huang, Daniel Q.
2b92f945-a7fb-4b34-8bf0-402d4991e929
Yoneda, Masato
9ff5455a-fde1-497f-b088-f3d422a70e8b
Li, Wenhao
55630e3a-52a1-4bbf-bf34-ec149907131f
Yilmaz, Yusuf
33d27e59-fddc-4950-b464-21fb6bfe5750
Tilg, Herbert
2a1f1540-0e25-48b6-872f-8033a76566fa
Wong, Vincent Wai-Sun
2edb798e-8930-4191-94f2-d22713f9678b
Zheng, Ming-Hua
986e37ab-28f9-4b26-afc5-9b2383df272a
Zhou, Xiao-Dong, Chen, Qin-Fen, Targher, Giovanni, Byrne, Chrisopher D., Valenti, Luca, Muthiah, Mark D., Kim, Seung Up, Huang, Daniel Q., Yoneda, Masato, Li, Wenhao, Yilmaz, Yusuf, Tilg, Herbert, Wong, Vincent Wai-Sun and Zheng, Ming-Hua
(2026)
Burden of metabolic dysfunction–associated steatotic liver disease in the Asia-Pacific region from 1990 to 2023.
eGastroenterology, 4 (1), .
(doi:10.1136/egastro-2026-100369).
Abstract
Background: metabolic dysfunction-associated steatotic liver disease (MASLD) is an increasing health problem in the Asia-Pacific region, contributing significantly to morbidity and healthcare burden. This study provides a comprehensive analysis of the burden of MASLD across countries and territories in the Asia-Pacific region from 1990 to 2023.
Methods: we used the Global Burden of Disease 2023 data set to assess the burden of MASLD in the Asia-Pacific region, calculating age-standardised prevalence, incidence, death and disability-adjusted life year (DALY) rates. Temporal trends, age-specific and sex-specific patterns, and the relationship between MASLD burden and Socio-demographic Index (SDI) were also analysed, along with regional variations driven by ageing, population growth and epidemiological changes.
Results: in 2023, MASLD prevalence varied across the Asia-Pacific region, with the highest rates in Oceania (15 360.55 per 100 000), Central Asia (15 201.10 per 100 000), South-East Asia (15 116.91 per 100 000) and East Asia (15 042.06 per 100 000), and lower rates in Australasia (9336.02 per 100 000) and high-income regions (8654.71 per 100 000). Over the past three decades, MASLD prevalence has increased across all regions, with the largest growth in Australasia (29%) and East Asia (27%). In addition, marked regional disparities were observed in age-standardised death and DALY rates, with Central Asia exhibiting the highest health loss across the region. Age-stratified analyses revealed that the highest incidence occurred in individuals aged 20–24 years in 2023. MASLD burden followed an inverse U-shaped pattern with SDI, increasing in regions with lower SDI and decreasing in those above 0.62. Population growth and lifestyle changes were the primary drivers of MASLD in East Asia, while ageing significantly contributed to the rising burden in South Asia.
Conclusions: MASLD is increasingly prevalent across the Asia-Pacific region, driven by ageing, population growth and epidemiological changes, with significant regional variations in the disease burden.
Text
manuscript
- Accepted Manuscript
Text
Figure 1
- Accepted Manuscript
Text
Figure 2
- Accepted Manuscript
Text
Figure 3
- Accepted Manuscript
Text
Supplemental material
- Accepted Manuscript
Text
e100369.full
- Version of Record
Show all 6 downloads.
More information
Accepted/In Press date: 10 March 2026
e-pub ahead of print date: 31 March 2026
Published date: 31 March 2026
Keywords:
Fatty Liver, Global Burden of Disease, Metabolic diseases, Non-alcoholic Fatty Liver Disease, Socioeconomic Factors
Identifiers
Local EPrints ID: 511345
URI: http://eprints.soton.ac.uk/id/eprint/511345
ISSN: 2766-0125
PURE UUID: 63e7cab9-f8fe-4f10-aa7f-a0612bf213f3
Catalogue record
Date deposited: 12 May 2026 16:46
Last modified: 13 May 2026 01:37
Export record
Altmetrics
Contributors
Author:
Xiao-Dong Zhou
Author:
Qin-Fen Chen
Author:
Giovanni Targher
Author:
Luca Valenti
Author:
Mark D. Muthiah
Author:
Seung Up Kim
Author:
Daniel Q. Huang
Author:
Masato Yoneda
Author:
Wenhao Li
Author:
Yusuf Yilmaz
Author:
Herbert Tilg
Author:
Vincent Wai-Sun Wong
Author:
Ming-Hua Zheng
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics